Weight Loss-Induced Calciphylaxis: Potential Role of Matrix Metalloproteinases

Journal of Dermatology

Volumn 30, Issue 12, 2003, Pages 915-919

  Munavalli, Girish ^a   Reisenauer, Amy ^a   Moses, Marsha ^b   Kilroy, Susan ^b   Arbiser, Jack L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Calciphylaxis; Matrix metalloproteinase; Obesity

Indexed keywords

CALCIUM; ELASTIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIFICATION; CALCINOSIS; CASE REPORT; CLINICAL FEATURE; ENZYME ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFARCTION; KIDNEY FUNCTION; PROTEIN DEGRADATION; RADIOGRAPHY; WEIGHT REDUCTION;

EID: 0942298660     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2003.tb00348.x     Document Type: Article

References (16)

1. Vyavahare N, Ogle M, Schoen FJ, Levy RJ: Elastin calcification and its prevention with aluminum chloride pretreatment, Am J Pathol, 155: 973-982, 1999.
2. Vyavahare N, Jones PL, Tallapragada S, Levy RJ: Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats, Am J Pathol, 157: 885-893, 2000.
3. Arbiser JL, Moses MA, Fernandez CA, et al: Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways, Proc Natl Acad Sci U S A, 94: 861-866, 1997.
4. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors, J Biol Chem, 261: 2814-2818, 1986.
5. Yan L, Borregaard N, Kjeldsen L, Moses MA: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL, J Biol Chem, 276: 37258-37265, 2001.
6. Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR: Increased incidence of matrix metalloproteinases in urine of cancer patients, Cancer Res, 58: 1395-1399, 1998.
7. Walsh JS, Fairley JA: Calciphylaxis, J Am Acad Dermatol, 35: 786-787, 1996.
8. Oh DH, Eulau D, Tokugawa DA, McGuire JS, Kohler S: Five cases of calciphylaxis and a review of the literature, J Am Acad Dermatol, 40: 979-987, 1999.
9. Mastruserio DN, Nguyen EQ, Nielsen T, Hessel A, Pellegrini AE: Calciphylaxis associated with metastatic breast carcinoma, J Am Acad Dermatol, 41: 295-298, 1999.
10. Wilmer WA, Magro CM: Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment, Semin Dial, 15: 172-186, 2002.
11. Raza SL, Cornelius LA: Matrix metalloproteinases: Pro- and anti-angiogenic activities, J Investig Dermatol Symp Proc, 5: 47-54, 2000.
12. Moses MA, Marikovsky M, Harper JW, et al: Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing, J Cell Biochem, 60: 379-386, 1996.
13. Coates T, Kirkland GS, Dymock RB, et al: Cutaneous necrosis from calcific uremic arteriolopathy, Am J Kidney Dis, 32: 384-391, 1998.
14. Ebihara I, Nakamura T, Tomino Y, Shimada N, Koide H: Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure, Am J Nephrol, 18: 305-310, 1998.
15. Lonnemann G, Koch KM: Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis, Nephrol Dial Transplant, 16 (Suppl 4): 17-22, 2001.
16. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R: Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells, Am J Pathol, 160: 2001-2008, 2002.